A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Apple issues iPhone 12 update over radiation concerns
Mysterious 'fairy circles' are spreading across the world and scientists don't know why
Transact Campus Secures One Million Mobile Credentials
Ant Group fined $985 million by Chinese regulators
Tesla to Surge Thanks to Dojo Supercomputer, Morgan Stanley Says
Musk’s X Sues California Over Content Moderation Legislation
DHL, Sasol Agree to Produce Sustainable Aviation Fuel in Germany
UK Geothermal Sites Near Financial Close After Auction Win